All News GlucoTrack, Inc.

Equities

GCTK

US45824Q5071

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
0.5501 ^USD	+1.70%		-5.33%	+110.36%

Apr. 22	GlucoTrack, Inc. announced that it has received $0.5 million in funding	CI
Apr. 16	Glucotrack Expanding Glucose Monitoring Technology to Epidural Space	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION	May. 02	AQ
GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT	Apr. 22	AQ
Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK	Apr. 22	AQ
GlucoTrack, Inc. announced that it has received $0.5 million in funding	Apr. 21	CI
Glucotrack Expanding Glucose Monitoring Technology to Epidural Space	Apr. 16	MT
GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING	Apr. 16	AQ
GlucoTrack, Inc. Announces Expansion of its Continues Glucose Monitoring Technology to Epidural Glucose Monitoring	Apr. 16	CI
GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR	Apr. 02	AQ
Glucotrack Announces Increased Sensor Longevity for Its Implantable Continuous Blood Glucose Monitor	Apr. 02	CI
GlucoTrack, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY	Mar. 12	AQ
GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR	Feb. 27	AQ
GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAVÉ TO CHAIR OF THE BOARD OF DIRECTORS	Feb. 13	AQ
Glucotrack, Inc Announces Appointment of Luis Malavé as Chairman of Its Board of Directors	Feb. 13	CI
GlucoTrack Says Implantable Glucose Monitor Safe With High Level of Accuracy; Shares Rise	Jan. 02	MT
GlucoTrack, Inc. Announces Early Accuracy Data for its Implantable Continuous Glucose Monitor	Jan. 02	CI
GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR	Jan. 02	AQ
GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT	Nov. 30	AQ
GlucoTrack, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
GLUCOTRACK ANNOUNCES SHAREHOLDER UPDATE	Nov. 13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News GlucoTrack, Inc.

Equities

GCTK

US45824Q5071

All News

Filters